Last updated on December 2018

Evaluation of Valiant Mona LSA


Brief description of study

The purpose of the Feasibility study is to characterize the safety of the Valiant Mona LSA Thoracic Stent Graft System, including an assessment of the safety and effectiveness of the device acutely and at the 30 day visit in the identified subject population. This study will also evaluate the current instructions for use and may direct changes to the delivery and deployment steps.

The purpose of the expansion to the Feasibility Study is to characterize the Valiant Mona LSA Thoracic Stent Graft System, in particular to assess the safety and effectiveness of the device acutely and at the 30 day visit, in subjects enrolled with chronic, Type B dissections.

Clinical Study Identifier: NCT02365467

Contact Investigators or Research Sites near you

Start Over

Greg Minisman

University of Alabama at Birmingham
Birmingham, AL United States
  Connect »

Aamir Shah, MD

Cedars-Sinai Medical Center
Los Angeles, CA United States
  Connect »

Javairiah Fatima, MD

University of Florida Shands Hospital
Gainesville, FL United States
  Connect »

William Jordan, MD

Emory Healthcare
Atlanta, GA United States
  Connect »

Frank Arko, MD

Carolinas Medical Center
Charlotte, NC United States
  Connect »

Eric Roselli, MD

Cleveland Clinic
Cleveland, OH United States
  Connect »

Nimesh D Desai, MD PhD

Hospital of the University of Pennsylvania
Philadelphia, PA United States
  Connect »

Joseph Coselli, MD

Baylor St. Lukes Medical Center
Houston, TX United States
  Connect »

Jean Panneton, MD

Sentara Norfolk General Hospital
Norfolk, VA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.